Prof. Mikhail Blagosklonny is one of the top science brains in the world, having taught, conducted research, and authored within the field of science. He was born in Russia but lives in the U.S. Currently based at Roswell Park Cancer Institute, Mikhail previously plied his trade at Ordway Research Institute in Albany as the senior scientist.
As a dean of Oncology at Roswell Park, Mikhail Blagosklonny is tasked with the responsibility of supervising research projects in the area of oncology as well as teaching oncology students. Mikhail has also been conducting research and formulating new concepts in Oncology for the last eight years. His other areas of interest include, among others, cancer biology, apoptosis, cell cycle, and mitosis. He significantly contributed to oncology research during his days at Ordway.
Mikhail’s Education Background
Mikhail sharpened his research skills at First Pavlov State Medical University of St. Petersburg, Russia. He studied internal medicine at the undergraduate level and specialized in experimental medicine and cardiology at Ph.D. level. He later left Russia for the U.S. where he got a chance to work as an assistant lecturer at New York Medical College. Read more on Impact Journals.
TOR Hypothesis, Rapamycin and His Contribution to Anti-Aging
Mikhail is one of the scientists advocating for the use of Rapamycin as a drug to derail the aging process in humans. His argument is simple; given that aging is MTOR-driven, then the cancer drug can slow down developmental growth and consequently derail the aging process. He, however, notes that the process might be harmful if the necessary precautionary measures are not taken. Mikhail recently conducted a Biogerontology research that sparked a huge debate on life extension. He later developed a TOR Signaling hypothesis that suggested that TOR Signaling could provide a breakthrough in the ongoing development of anti-aging therapies.
Mikhail boasts about 300 peer-reviewed journals. The most known are two journals published by Impact Journals: Oncotarget, which is published weekly, and Aging monthly journal. He is a senior editor of Oncotarget together with his colleague at Roswell Park, Prof. Andrei Gudkov. Mikhail is the founding editor of Cell Cycle, a journal of cell biology that is published twice a week. View more http://www.tandfonline.com/doi/pdf/10.4161/cbt.8.9.8899